Diagnostics and Tools September 2023

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

  • Gedi Cube was acquired by Renovaro Biosciences Inc. (NasdaqCM:RENB)
  • Repligen Corporation (NasdaqGS:RGEN) announced its acquisition of Metenova AB
  • Harbinger Health closed a $140MM Series A Financing, led by Flagship Pioneering

Download the BlueBook